Na Zeng

Papers

Total Citations

H-Index

About

Na Zeng is a leading figure in urologic oncology, with a primary research focus on optimizing surgical outcomes for prostate cancer. Her major contribution lies in the rigorous comparative evaluation of robotic-assisted radical prostatectomy (RARP) against traditional open and laparoscopic approaches. In her landmark 2024 systematic review and network meta-analysis, Zeng synthesized global clinical data to demonstrate RARP’s superior perioperative outcomes, including reduced blood loss and shorter hospital stays, while maintaining comparable oncologic control. This work, already garnering 7 citations, has provided crucial evidence for surgical decision-making in localized prostate cancer. Zeng’s research bridges the gap between technological innovation and clinical practice, offering urologists a data-driven framework for selecting the most effective surgical modality. Her meticulous methodology and clear reporting have made her a trusted voice in evidence-based urology, influencing treatment guidelines and shaping the adoption of robotic surgery worldwide. For students and researchers, Zeng’s work exemplifies how systematic reviews can translate complex clinical data into actionable insights, advancing both surgical precision and patient care.